BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26956973)

  • 21. Roles of Tristetraprolin in Tumorigenesis.
    Park JM; Lee TH; Kang TH
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition of proliferation in MCF-7 breast cancer cells by plasmid-based siRNA targeting to oncogene c-myc].
    Zhou CH; Peng XD; Wu J; Zhang P; Zhao ZR; Wei DP; Zhang CJ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 May; 39(3):373-7. PubMed ID: 18575318
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
    Huang L; Yu Z; Zhang Z; Ma W; Song S; Huang G
    Sci Rep; 2016 Mar; 6():22449. PubMed ID: 26926077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.
    Hau HH; Walsh RJ; Ogilvie RL; Williams DA; Reilly CS; Bohjanen PR
    J Cell Biochem; 2007 Apr; 100(6):1477-92. PubMed ID: 17133347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tristetraprolin down-regulates IL-23 expression in colon cancer cells.
    Lee HH; Yang SS; Vo MT; Cho WJ; Lee BJ; Leem SH; Lee SH; Cha HJ; Park JW
    Mol Cells; 2013 Dec; 36(6):571-6. PubMed ID: 24292977
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autocrine human growth hormone increases sensitivity of mammary carcinoma cell to arsenic trioxide-induced apoptosis.
    Zekri A; Ghaffari SH; Yousefi M; Ghanizadeh-Vesali S; Mojarrad M; Alimoghaddam K; Ghavamzadeh A
    Mol Cell Endocrinol; 2013 Sep; 377(1-2):84-92. PubMed ID: 23851143
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SRC Increases
    Abdullah C; Korkaya H; Iizuka S; Courtneidge SA
    Mol Cell Biol; 2018 Mar; 38(6):. PubMed ID: 29263157
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of c-Myc expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo.
    Wang YH; Liu S; Zhang G; Zhou CQ; Zhu HX; Zhou XB; Quan LP; Bai JF; Xu NZ
    Breast Cancer Res; 2005; 7(2):R220-8. PubMed ID: 15743499
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor suppressing effects of tristetraprolin and its small double-stranded RNAs in bladder cancer.
    Jiang W; Zhu D; Wang C; Zhu Y
    Cancer Med; 2021 Jan; 10(1):269-285. PubMed ID: 33259133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Membrane-bound melatonin receptor MT1 down-regulates estrogen responsive genes in breast cancer cells.
    Girgert R; Hanf V; Emons G; Gründker C
    J Pineal Res; 2009 Aug; 47(1):23-31. PubMed ID: 19522736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-proliferative effects of γ-tocotrienol are associated with suppression of c-Myc expression in mammary tumour cells.
    Parajuli P; Tiwari RV; Sylvester PW
    Cell Prolif; 2015 Aug; 48(4):421-35. PubMed ID: 26096843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tristetraprolin mediates anti-inflammatory effects of nicotine in lipopolysaccharide-stimulated macrophages.
    Joe Y; Kim HJ; Kim S; Chung J; Ko MS; Lee WH; Chang KC; Park JW; Chung HT
    J Biol Chem; 2011 Jul; 286(28):24735-42. PubMed ID: 21606497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tristetraprolin impairs myc-induced lymphoma and abolishes the malignant state.
    Rounbehler RJ; Fallahi M; Yang C; Steeves MA; Li W; Doherty JR; Schaub FX; Sanduja S; Dixon DA; Blackshear PJ; Cleveland JL
    Cell; 2012 Aug; 150(3):563-74. PubMed ID: 22863009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thymoquinone-Induced Tristetraprolin Inhibits Tumor Growth and Metastasis through Destabilization of MUC4 mRNA.
    Lee SR; Mun JY; Jeong MS; Lee HH; Roh YG; Kim WT; Kim MH; Heo J; Choi YH; Kim SJ; Cha HJ; Jun M; Leem SH
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31141941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone deacetylase inhibitors sensitize human non-small cell lung cancer cells to ionizing radiation through acetyl p53-mediated c-myc down-regulation.
    Seo SK; Jin HO; Woo SH; Kim YS; An S; Lee JH; Hong SI; Lee KH; Choe TB; Park IC
    J Thorac Oncol; 2011 Aug; 6(8):1313-9. PubMed ID: 21642861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth factor-dependent regulation of survivin by c-myc in human breast cancer.
    Cosgrave N; Hill AD; Young LS
    J Mol Endocrinol; 2006 Dec; 37(3):377-90. PubMed ID: 17170079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of RNA-binding protein tristetraprolin in cancer and immunity.
    Guo J; Qu H; Chen Y; Xia J
    Med Oncol; 2017 Nov; 34(12):196. PubMed ID: 29124478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RNA binding protein tristetraprolin down-regulates autophagy in lung adenocarcinoma cells.
    Dong F; Li C; Wang P; Deng X; Luo Q; Tang X; Xu L
    Exp Cell Res; 2018 Jun; 367(1):89-96. PubMed ID: 29577897
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone Deacetylase Inhibitors Activate Tristetraprolin Expression through Induction of Early Growth Response Protein 1 (EGR1) in Colorectal Cancer Cells.
    Sobolewski C; Sanduja S; Blanco FF; Hu L; Dixon DA
    Biomolecules; 2015 Aug; 5(3):2035-55. PubMed ID: 26343742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function.
    Berglund AE; Scott KE; Li W; Yang C; Fernandez MR; Schaub FX; Cleveland JL; Rounbehler RJ
    Oncotarget; 2016 Dec; 7(50):83462-83475. PubMed ID: 27825143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.